CLOVES syndrome: Treatment with oral Rapamycin. Report of two cases

Simple item page
dc.contributor.authorDe Grazia, Renatta
dc.contributor.authorGiordano, Consuelo
dc.contributor.authorCossio, Laura
dc.contributor.authorDowney, Camila
dc.contributor.authorDelucchi, Ángela
dc.contributor.authorKramer, Daniela
dc.date.accessioned2022-07-07T20:21:06Z
dc.date.available2022-07-07T20:21:06Z
dc.date.issued2019
dc.description.abstractIntroduction: CLOVES syndrome is characterized by lipomatous overgrowth associated with vascular malforma tions, representing a diagnostic and a therapeutic challenge. Rapamycin, an mTOR inhibitor, has proved to be a good therapeutic option in some vascular anomalies. In this article, we report two ca ses of CLOVES syndrome with good response to oral rapamycin treatment. Objective: To report the outcome of two patients with CLOVES syndrome treated with oral rapamycin. Clinical cases: Case 1: A three-year-old female preschooler with CLOVES syndrome and history of repeated hospita lizations due to severe infections resulting from macrocystic lymphatic malformations and due to thrombotic episodes. The patient evolved with poor quality of life, multiple hospitalizations, surgical risk and progression of the lesions, therefore, oral rapamycin was indicated. After six months of treatment, clinical and radiological reduction in the size of the lipomatous and lymphatic masses, cutaneous lymphorrhea absence and a significant improvement of her quality of life were observed, without requiring new hospitalizations. Case 2: a ten-year-old female schooler with CLOVES syndro me, who developed scoliosis and deterioration of her motor skills, becoming wheelchair-dependent. Oral rapamycin was indicated, showing improvement in her physical capacity, independence and au tonomy, and absence of lymphorrhea after four months of treatment. Conclusion: We propose oral rapamycin for the treatment of patients with CLOVES syndrome who present with complications and deterioration in the quality of life as a result of the disease.es
dc.description.versionVersión publicadaes
dc.identifier.citationde Grazia R, Giordano C, Cossio L, Downey C, Delucchi Á, Kramer D. CLOVES syndrome: Treatment with oral Rapamycin. Report of two cases. Rev Chil Pediatr. 2019 Dec;90(6):662-667. English, Spanish. doi: 10.32641/rchped.v90i6.1025es
dc.identifier.urihttps://doi.org/10.32641/rchped.v90i6.1025es
dc.identifier.urihttp://hdl.handle.net/11447/6323
dc.language.isoenes
dc.subjectAntibiotics, Antineoplastic / administration & dosagees
dc.subjectAntibiotics, Antineoplastic / therapeutic usees
dc.subjectMusculoskeletal Abnormalities / drug therapyes
dc.subjectChild, Preschooles
dc.subjectChildes
dc.subjectLipoma / drug therapyes
dc.subjectSirolimus / administration & dosagees
dc.subjectSirolimus / therapeutic usees
dc.subjectVascular Malformations / drug therapyes
dc.titleCLOVES syndrome: Treatment with oral Rapamycin. Report of two caseses
dc.typeArticlees
dcterms.sourceRevista chilena de pediatríaes

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
CLOVES syndrome Treatment with oral Rapamycin. Report of two cases.pdf
Size:
654.85 KB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services